Development of steroid-resistant nephrotic syndrome in a child with CAKUT-syndrome

BACKGROUND. One of the congenital anomalies of the kidneys and urinary tracts (CAKUT) is renal hypodysplasia/aplasia type 3 (PHDA3), caused by pathogenic variants in the GREB1L gene not associated with steroid-resistant nephrotic syndrome (SRNS). PGDA3 leads to chronic kidney disease (CKD). Variants in the UMOD gene associated with autosomal dominant tubulointerstitial kidney disease (ATKD-UMOD) also lead to CKD. The association of the GREB1L/UMOD genes with SRNS has not been previously described.

THE AIM: to demonstrate a rare clinical case of SRNS in a child with CAKUT-syndrome.

PATIENTS AND METHODS. A patient with CAKUT in the form of PGDA3 and ADTBP-UMOD is observed in the department of nephrology for 2 years. Post-infectious development of SRNS required a revision of the genetic screening.

RESULTS. On the whole-genome sequencing were found a variability in the genes that cause CAKUT, with no candidate genes for SRNS.

CONCLUSION. The described case stands out with clinical polymorphism of CAKUT and the variability of UMOD and GREB1L gene variants not associated with the development of SRNS. Infectious etiology of the development of SRNS is assumed. The patient has an intensive development of CKD stage 4, requiring a long-term follow-up in dynamics.

1. Kutyrlo IE, Savenkova ND. CAKUT – syndrome in children. Nephrology (Saint-Petersburg) 2017;21(3):18–24. (In Russ.) doi: 10.24884/1561-6274-2017-3-18-24

2. Wang A, Ji B, Wu F, Zhao X. Clinical Exome Sequencing Identifies a Novel Mutation of the GREB1L Gene in a Chinese Family with Renal Agenesis. Genetic Testing and Molecular Biomarkers 2020. doi:10.1089/gtmb.2020.0036

3. Brophy PD, Rasmussen M, Parida M et al. A Gene Implicated in Activation of Retinoic Acid Receptor Targets Is a Novel Renal Agenesis Gene in Humans. Genetics 2017; 207(1): 215–228. doi:10.1534/genetics.117.1125

4. Murugapoopathy V, Gupta IR. A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT). Clin J Am Soc Nephrol 2020 May 7;15(5):723–731. doi: 10.2215/CJN.12581019. Epub 2020 Mar 18. PMID: 32188635; PMCID: PMC7269211

5. Al-Hamed MH, Sayer JA, Alsahan N et al. Novel loss of function variants in FRAS1 AND FREM2 underlie renal agenesis in consanguineous families. Journal of Nephrology 2020. doi: 10.1007/s40620-020-00795-0

6. Khoshdel Rad N, Aghdami N, Moghadasali R. Cellular and Molecular Mechanisms of Kidney Development: From the Embryo to the Kidney Organoid. Front Cell Dev Biol 2020 Mar 24;8:183. doi: 10.3389/fcell.2020.00183. PMID: 32266264; PMCID: PMC7105577

7. Jordan P, Dorval G, Arrondel C et al. Targeted next-generation sequencing in a large series of fetuses with severe renal diseases. Hum Mutat 2022 Mar;43(3):347–361. doi: 10.1002/humu.24324. Epub 2022 Jan 10. PMID: 3500581

8. Wu S, Wang X, Dai S, Zhang G et al. A novel missense mutation in GREB1L identified in a three-generation family with renal hypodysplasia/aplasia-3. Orphanet J Rare Dis 2022 Nov 12;17(1):413. doi: 10.1186/s13023-022-02553-w. PMID: 36371238; PMCID: PMC9652819

9. Mihaly Varadi, Stephen Anyango, Mandar Deshpande et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Research, Volume 50, Issue D1, 7 January 2022, Pages D439–D444; doi: 10.1093/nar/gkab1061 https://www.genecards.org/cgi-bin/carddisp.pl?gene=GREB1L

10. Buchert R, Schenk E, Hentrich T et al. Genome Sequencing and Transcriptome Profiling in Twins Discordant for Mayer-Rokitansky-Küster-Hauser Syndrome. J Clin Med 2022 Sep 23;11(19):5598. doi: 10.3390/jcm11195598. PMID: 36233463; PMCID: PMC9573672

11. Yu Y, Wang Z, Zheng Q, Li J. GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma. Scientific Reports 2021;11(1). doi: 10.1038/s41598-021-92695-x

12. Kayukov IG, Dobronravov VA, Beresneva ON, Smirnov AV. Autosomal dominant tubulointerstitial kidney disease. Nephrology (SaintPetersburg) 2018;22(6):9–22. (In Russ.) doi: 10.24884/1561-6274-2018-22-6-9-22

13. Schrauwen I, Liaqat K, Schatteman I et al. Autosomal Dominantly Inherited GREB1L Variants in Individuals with Profound Sensorineural Hearing Impairment. Genes 2020;11(6):687. doi: 10.3390/genes11060687

14. De Tomasi L, David P, Humbert C et al. Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice. Am J Hum Genet 2017 Nov 2;101(5):803–814. doi: 10.1016/j.ajhg.2017.09.026. PMID: 29100091; PMCID: PMC5673669

15. Jacquinet A, Boujemla B, Fasquelle C et al. GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer-Rokitansky-Kuster-Hauser syndrome. Clin Genet 2020 Aug;98(2):126–137. doi: 10.1111/cge.13769. Epub 2020 May 25. PMID: 32378186

16. Rasmussen M, Sunde L, Nielsen ML et al. Targeted gene sequencing and whole-exome sequencing in autopsied fetuses with prenatally diagnosed kidney anomalies. Clin Genet 2018 Apr; 93(4):860–869. doi: 10.1111/cge.13185. Epub 2018 Feb 23. PMID: 29194579

17. Sanna-Cherchi S, Khan K, Westland R et al. Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations. The American Journal of Human Genetics 2017;101(5):789–802. doi: 10.1016/j.ajhg.2017.09.018

18. Herlin MK, Petersen MB, Brännström M. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update. Orphanet J Rare Dis 2020;15:214. doi: 10.1186/s13023-02001491-9

19. Eckardt K-U, Alper SL, Antignac C et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management–A KDIGO consensus report. Kidney International 2015;88(4):676–683. doi:10.1038/ki.2015.28

20. Olinger E, Hofmann P, Kidd K et al. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int 2020 Sep;98(3): 717–731. doi: 10.1016/j.kint.2020.04.038. Epub 2020 May 22. PMID: 32450155

21. Westland R, Schreuder MF, Ket JCF, van Wijk JAE. Unilateral renal agenesis: a systematic review on associated anomalies and renal injury. Nephrology Dialysis Transplantation 2013;28(7): 1844–1855. doi:10.1093/ndt/gft012

22. Warejko JK, Tan W, Daga A et al. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology 2017;13(1):53–62. doi:10.2215/cjn.04120417

23. Arora V, Anand K, Chander Verma I. Genetic Testing in Pediatric Kidney Disease. Indian J Pediatr 2020 Sep;87(9):706–715. doi: 10.1007/s12098-020-03198-y. Epub 2020 Feb 13. PMID: 32056192

24. Trautmann A, Vivarelli M, Samuel S et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatric Nephrology 2020. doi:10.1007/s00467-020-04519-1

25. Stevenson M, Pagnamenta AT, Reichart S et al. Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia. Am J Med Genet A 2020 Nov;182(11):2521–2528. doi: 10.1002/ajmg.a.61814. Epub 2020 Aug 9. PMID: 32776440; PMCID: PMC7611017

26. Vivante A, Chacham OS, Shril S et al. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children. Pediatr Nephrol 2019 Sep;34(9):1607–1613. doi: 10.1007/s00467-019-04256-0. Epub 2019 Apr 17. PMID: 31001663; PMCID: PMC6660980

27. Yamamura Y, Furuichi K, Murakawa Y et al. Identification of candidate PAX2-regulated genes implicated in human kidney development. Sci Rep 2021 Apr 27;11(1):9123. doi: 10.1038/s41598-021-88743-1. PMID: 33907292; PMCID: PMC8079710

28. Cirio MC, de Groh ED, de Caestecker MP, Davidson AJ et al. Kidney regeneration: common themes from the embryo to the adult. Pediatric Nephrology (Berlin, Germany) 2014 Apr;29(4):553–564. doi: 10.1007/s00467-013-2597-2. PMID: 24005792; PMCID: PMC3944192